Study guide
5.3 Dialysate Composition & Concentrate Formulations
BONENT Certified Hemodialysis Nurse CHN
Track your progress as you read
Finished sections get a check mark.
1 Exam Orientation
1.1 Current CHN Exam Facts and Study Strategy
2 Chapter 1: Renal Anatomy, Physiology & CKD Pathophysiology
2.1 Nephron Physiology & Endocrine Functions 2.2 Acute Kidney Injury & Chronic Kidney Disease Staging 2.3 Fluid, Electrolyte & Acid-Base Imbalances in ESRD
3 Chapter 2: CKD-MBD, Uremia & Clinical Manifestations
3.1 CKD-Mineral and Bone Disorder (CKD-MBD) 3.2 Uremic Syndrome & Multi-System Complications 3.3 Dialysis Patient Education & Nutritional Management
4 Individualized Nursing Care
4.1 Nursing Assessment, Planning and Evaluation 4.2 Treatment Records and Safe Handoffs 4.3 Psychosocial Assessment, Counseling and Referral
5 Chapter 3: Principles of Hemodialysis & Dialysate Chemistry
5.1 Transport Mechanisms: Diffusion, Convection & Ultrafiltration 5.2 Dialyzer Characteristics, Membrane Biocompatibility & Flux 5.3 Dialysate Composition & Concentrate Formulations 5.4 Hemodialysis Adequacy: Urea Kinetics, Kt/V & URR
6 Chapter 4: Vascular Access: Fistulas, Grafts & Catheters
6.1 Arteriovenous Fistulas & Arteriovenous Grafts 6.2 Physical Examination, Surveillance & Monitoring of Access 6.3 Central Venous Catheters & CDC Infection Prevention
7 Chapter 5: Cannulation Practice & Access Complications
7.1 Cannulation Techniques: Rope-Ladder, Buttonhole & Needle Sizing 7.2 Vascular Access Stenosis, Thrombosis & Steal Syndrome 7.3 Access Infiltration, Pseudoaneurysms & Hemorrhage Management
8 Chapter 6: Hemodialysis Treatment Delivery & Circuit Monitoring
8.1 Pre-Dialysis Assessment, Target Dry Weight & UFR Limits 8.2 Extracorporeal Circuit Setup, Priming & Safety Alarms 8.3 Anticoagulation Management: Heparin Protocols & Citrate 8.4 Treatment Termination, Hemostasis & Post-Dialysis Assessment
9 Equipment and Laboratory Skills
9.1 Ancillary Equipment and Bedside Safety 9.2 Blood Sampling, Laboratory Trends and Critical Results
10 Chapter 7: Acute Intradialytic Complications & Emergencies
10.1 Intradialytic Hypotension & Muscle Cramping 10.2 Dialysis Disequilibrium Syndrome & Neurological Events 10.3 Dialyzer Reactions & Hypersensitivity (Type A and Type B) 10.4 Critical Emergencies: Air Embolism, Hemolysis & Blood Loss
11 Extended and Acute Treatment
11.1 Sequential UF, Hemofiltration and Hemoperfusion 11.2 Acute Kidney Injury and High-Risk Dialysis Initiation
12 Chapter 8: Nephrology Pharmacology in Hemodialysis
12.1 Anemia Management: ESAs & Intravenous Iron Therapy 12.2 CKD-MBD Pharmacotherapy: Binders, Vitamin D & Calcimimetics 12.3 Cardiovascular, Antimicrobial & Dialyzable Drug Dosing
13 Home and Peritoneal Dialysis
13.1 Home Dialysis Selection and Adult Learning 13.2 Home Setup, Monitoring and Emergency Readiness 13.3 Peritoneal Dialysis Principles and Nursing Care
14 Kidney Transplantation
14.1 Transplant Benefits, Burdens and Modality Counseling 14.2 Transplant Indications, Contraindications and Referral 14.3 Pretransplant Workup and Waiting-List Coordination 14.4 Immunosuppressants, Interactions and Patient Teaching 14.5 Returning to Dialysis After Graft Failure 14.6 New-Graft Monitoring and Urgent Changes
15 Chapter 9: Water Treatment Systems & Dialyzer Reprocessing
15.1 AAMI/ISO Water Treatment Architecture & Components 15.2 Chemical Contaminant Monitoring & Total Chlorine Testing 15.3 Microbiological Standards, Endotoxin Surveillance & Sampling 15.4 Dialyzer Reprocessing Standards, Testing & Germicide Safety
16 Clinical Unit Management
16.1 Evaluating Dialysis Technology and Supplies 16.2 Staffing, Personnel Policies and Standards of Care
17 Chapter 10: Supervision, Administration & Professional Practice
17.1 RN Delegation, Technician Supervision & Nurse Practice Acts 17.2 CMS Conditions for Coverage & Interdisciplinary Care Planning 17.3 Dialysis Unit Infection Control & Environmental Safety 17.4 Quality Improvement (ESRD QIP), Ethics & Palliative Care
18 Professional Development
18.1 Professional Literature, Organizations and Continuing Learning 18.2 Research Design, Implementation and Evidence Interpretation 18.3 Staff Training, Competency and Remediation
19 Environmental Hazards and Emergency Planning
19.1 Chemical Agents, Disinfection and Exposure Control 19.2 Biological Hazards and Occupational Injury Response 19.3 Fire, Threats and Power or Water Interruptions
5.3 Dialysate Composition & Concentrate Formulations
Key Takeaways Explain This Topic AI
The proportioning system blends purified reverse osmosis (RO) water, acid concentrate ('A'), and bicarbonate concentrate ('B') in precise ratios to formulate physiological dialysate.
Acid and bicarbonate concentrates must remain strictly separated until immediately prior to mixing to prevent insoluble precipitation of calcium carbonate and magnesium carbonate.
Dialysate potassium is prescribed from current laboratory and clinical factors; low potassium can increase arrhythmia risk, including with digoxin.
Verify the prescribed dialysate temperature and device limits; an unsafe deviation requires protection and correction.
Verify the prescription, concentrate identity and the device-required independent conductivity, pH and residual tests before connection; acceptable limits depend on the formulation and instructions.
Last updated: October 2026
Dialysate Composition & Concentrate Formulations
Dialysate is an aqueous electrolyte solution formulated to correct uremic imbalances, restore acid-base homeostasis, and normalize extracellular fluid composition. Circulating through the dialyzer shell space, dialysate exchanges solutes and water with blood across capillary fibers. Because 90 to 150 liters of dialysate interact with blood each session, formulation errors can rapidly cause life-threatening electrolyte shifts, arrhythmias, or acute hemolysis. The Certified Hemodialysis Nurse (CHN) must understand concentrate chemistry, electrolyte prescription targets, and mandatory independent verification protocols.
Automated Proportioning Systems
Modern hemodialysis delivery machines blend purified reverse osmosis (RO) water with two concentrates on demand:
Acid Concentrate ("A"): Contains electrolytes, dextrose, and an organic acid.
Bicarbonate Concentrate ("B"): Contains sodium bicarbonate and sodium chloride.
Standard Proportioning Ratios
Proportioning systems mix water and concentrates in calibrated volumetric ratios:
45X Formulation: 1 part acid : 1.72 parts bicarbonate : 42.28 parts RO water (Total = 45 parts).
35X Formulation: 1 part acid : 1.4 parts bicarbonate : 32.6 parts RO water (Total = 35 parts).
Concentrate formulations and machine calibration codes must match exactly to avoid severe hypo- or hypernatremia.
Chemical Rationale for Concentrate Separation
Concentrates cannot be pre-mixed into a single container due to chemical incompatibility between divalent cations and bicarbonate: C a 2 + + 2 H C O 3 − ⟶ C a C O 3 ↓ + H 2 O + C O 2 Ca^{2+} + 2HCO_3^- \longrightarrow CaCO_3 \downarrow + H_2O + CO_2 C a 2 + + 2 H C O 3 − ⟶ C a C O 3 ↓ + H 2 O + C O 2 M g 2 + + 2 H C O 3 − ⟶ M g C O 3 ↓ + H 2 O + C O 2 Mg^{2+} + 2HCO_3^- \longrightarrow MgCO_3 \downarrow + H_2O + CO_2 M g 2 + + 2 H C O 3 − ⟶ M g C O 3 ↓ + H 2 O + C O 2
If concentrated calcium or magnesium contacts concentrated bicarbonate in an alkaline solution, insoluble calcium carbonate ( C a C O 3 CaCO_3 C a C O 3 , limestone) and magnesium carbonate ( M g C O 3 MgCO_3 M g C O 3 ) immediately precipitate as white chalky crystals. These precipitates clog valves, flowmeters, and dialyzer fibers. Keeping concentrates separate and blending them with RO water under automated control prevents precipitation.
Acid Concentrate Chemistry and Citrate Buffers
Acid Buffer: Acid concentrate is acidified to pH 2.0 to 3.0 using acetic acid (~4 mEq/L) or citric acid to maintain divalent cation solubility.
Citrate-Buffered Dialysate: Formulations containing citric acid (~2.4 mEq/L) chelate free ionized calcium within the dialyzer, reducing available calcium locally; this is not automatically equivalent to a prescribed regional citrate anticoagulation protocol. This reduces dialyzer clotting, lowers systemic heparin requirements, and enhances solute clearance.
Delivered Dialysate Electrolyte Parameters
Final dialysate electrolyte concentrations are prescribed to meet individual patient needs:
Sodium ( N a + Na^+ N a + : 135 to 145 mEq/L): Determines extracellular fluid osmolality. Setting dialysate sodium to match patient pre-dialysis serum sodium prevents acute osmolar shifts. Sodium modeling (ramping sodium from 145 to 138 mEq/L) temporarily reduces intradialytic cramps, but promotes post-dialysis thirst, high interdialytic weight gain (IDWG), and hypertension. Modern guidelines discourage routine sodium modeling.
Potassium ( K + K^+ K + : 0, 1.0, 2.0, 3.0, 4.0 mEq/L): Prescribed based on pre-dialysis potassium. Most chronic patients dialyze against a 2.0 or 3.0 mEq/L bath. In patients taking digoxin , low potassium baths (0 or 1.0 mEq/L) cause rapid hypokalemia, enhancing digoxin binding and triggering fatal ventricular arrhythmias; the nurse should flag the interaction and confirm the individualized potassium prescription.
Calcium ( C a 2 + Ca^{2+} C a 2 + : 2.0, 2.5, 3.0 mEq/L): Standard 2.5 mEq/L matches normal serum ionized calcium (~1.25 mmol/L), but does not guarantee neutral whole-body calcium balance. KDIGO suggests 2.5–3.0 mEq/L for CKD G5D, with individualization. Very low calcium can increase hypotension and arrhythmia risk; neither hypercalcemia nor low bone turnover authorizes the nurse to choose an unprescribed low bath.
Magnesium ( M g 2 + Mg^{2+} M g 2 + : 0.75 to 1.0 mEq/L): Maintained slightly below normal serum levels to allow modest diffusive removal and prevent hypermagnesemia in ESRD.
Chloride ( C l − Cl^- C l − : 100 to 110 mEq/L): Major balancing counter-anion.
Bicarbonate ( H C O 3 − HCO_3^- H C O 3 − : 32 to 38 mEq/L): Diffuses into blood to correct chronic metabolic acidosis ( H C O 3 − < 22 mEq/L HCO_3^- < 22\text{ mEq/L} H C O 3 − < 22 mEq/L ). Excessive bath bicarbonate (> 38 mEq/L) causes post-dialysis metabolic alkalosis, provoking hypokalemic arrhythmias, reduced ionized calcium (tetany and cramps), and hypoventilation.
Dextrose (100 to 200 mg/dL): Prevents hypoglycemia, reduces post-dialysis fatigue, and dampens rapid osmolar drops.
Independent Safety Testing: Conductivity, pH, and Temperature
Before initiating treatment, the nurse verifies prescription, concentrate formulation, residual clearance and fluid parameters through the device and facility procedure. The following numerical ranges are teaching examples, not universal limits:
Conductivity and Automated Bypass
Conductivity reflects total ionic concentration (primarily sodium), normally 13.0 to 15.0 mS/cm .
Machines contain redundant internal conductivity sensors. If conductivity deviates outside preset limits ( ± 0.2 − 0.4 mS/cm \pm 0.2-0.4\text{ mS/cm} ± 0.2 − 0.4 mS/cm ), the machine alarms and diverts dialysate to the drain via the bypass valve .
Hypotonic dialysate causes water to rush into red blood cells, causing acute hemolysis and hyperkalemic arrest.
Hypertonic dialysate causes cellular crenation, hypernatremia, and intracranial hemorrhage.
Independent testing: Before patient exposure, perform the delivery system’s required independent conductivity and pH verification using the approved calibrated method. Acceptance ranges depend on the formulation and device instructions; do not present one 6.9–7.6 pH range as the universal CMS requirement.
Temperature and Hemolysis Risk
Use the prescribed temperature and the delivery system’s validated alarm limits. Excessively hot fluid can injure blood cells, but 39°C is not a universal instantaneous hemolysis threshold. Temperature above the ordered range requires correction before exposure. Cool dialysate may improve hemodynamic tolerance but can cause discomfort and shivering; it is individualized rather than imposed on all patients.
Conductivity estimates total ionic content, not the identity of each ion. A wrong potassium or calcium concentrate may still yield plausible conductivity. Independently match the concentrate label, lot, mixing ratio and machine setting to the order, then perform the manufacturer’s required conductivity, pH and residual-disinfectant checks. Alarm bypass is a protective response, not permission to override the alarm and continue exposure. A bath change requires the same verification as initial setup.
Dialysate Formulation Reference
Component Normal Plasma Acid Concentrate ("A") Bicarbonate Concentrate ("B") Final Dialysate
Sodium ( N a + Na^+ N a + ) 135 − 145 mEq/L 135-145\text{ mEq/L} 135 − 145 mEq/L Concentrated ( N a C l NaCl N a Cl ) Concentrated ( N a H C O 3 NaHCO_3 N a H C O 3 ) 135 − 145 mEq/L 135-145\text{ mEq/L} 135 − 145 mEq/L
Potassium ( K + K^+ K + ) 3.5 − 5.0 mEq/L 3.5-5.0\text{ mEq/L} 3.5 − 5.0 mEq/L 0 − 140 mEq/L 0-140\text{ mEq/L} 0 − 140 mEq/L 0 mEq/L 0\text{ mEq/L} 0 mEq/L 0 − 4.0 mEq/L 0-4.0\text{ mEq/L} 0 − 4.0 mEq/L
Calcium ( C a 2 + Ca^{2+} C a 2 + ) 4.5 − 5.3 mEq/L 4.5-5.3\text{ mEq/L} 4.5 − 5.3 mEq/L Concentrated ( C a C l 2 CaCl_2 C a C l 2 ) 0 mEq/L 0\text{ mEq/L} 0 mEq/L 2.0 − 3.0 mEq/L 2.0-3.0\text{ mEq/L} 2.0 − 3.0 mEq/L
Magnesium ( M g 2 + Mg^{2+} M g 2 + ) 1.5 − 2.5 mEq/L 1.5-2.5\text{ mEq/L} 1.5 − 2.5 mEq/L Concentrated ( M g C l 2 MgCl_2 M g C l 2 ) 0 mEq/L 0\text{ mEq/L} 0 mEq/L 0.75 − 1.0 mEq/L 0.75-1.0\text{ mEq/L} 0.75 − 1.0 mEq/L
Chloride ( C l − Cl^- C l − ) 98 − 106 mEq/L 98-106\text{ mEq/L} 98 − 106 mEq/L Concentrated ( N a C l , K C l NaCl, KCl N a Cl , K Cl ) 0 mEq/L 0\text{ mEq/L} 0 mEq/L 100 − 110 mEq/L 100-110\text{ mEq/L} 100 − 110 mEq/L
Bicarbonate ( H C O 3 − HCO_3^- H C O 3 − ) 22 − 29 mEq/L 22-29\text{ mEq/L} 22 − 29 mEq/L 0 mEq/L 0\text{ mEq/L} 0 mEq/L Concentrated ( N a H C O 3 NaHCO_3 N a H C O 3 ) 32 − 38 mEq/L 32-38\text{ mEq/L} 32 − 38 mEq/L
Organic Acid Trace Acetic or Citric (~ 4 mEq/L 4\text{ mEq/L} 4 mEq/L ) 0 mEq/L 0\text{ mEq/L} 0 mEq/L 2 − 4 mEq/L 2-4\text{ mEq/L} 2 − 4 mEq/L
Glucose 70 − 110 mg/dL 70-110\text{ mg/dL} 70 − 110 mg/dL 3 , 500 − 7 , 000 mg/dL 3,500-7,000\text{ mg/dL} 3 , 500 − 7 , 000 mg/dL 0 mg/dL 0\text{ mg/dL} 0 mg/dL 100 − 200 mg/dL 100-200\text{ mg/dL} 100 − 200 mg/dL
pH Range 7.35 − 7.45 7.35-7.45 7.35 − 7.45 2.0 − 3.0 2.0-3.0 2.0 − 3.0 (acidic) 8.0 − 9.0 8.0-9.0 8.0 − 9.0 (alkaline) 6.9 − 7.6 6.9-7.6 6.9 − 7.6 (neutral)
Sources checked 2026-10-10: NIDDK HD ; current device and medication instructions govern product-specific details.
Device source checked 2026-10-11: Fresenius operator manuals, including 2008T revision AE . Examples explain principles; the actual device and chemical labeling govern operation.